Gardner Lewis Asset Management L P Chimerix Inc Transaction History
Gardner Lewis Asset Management L P
- $415 Million
- Q1 2025
A detailed history of Gardner Lewis Asset Management L P transactions in Chimerix Inc stock. As of the latest transaction made, Gardner Lewis Asset Management L P holds 775,426 shares of CMRX stock, worth $6.62 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
775,426Holding current value
$6.62 Million% of portfolio
1.59%Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
88Shares Held
46.1MCall Options Held
243KPut Options Held
110K-
Ra Capital Management, L.P. Boston, MA8.8MShares$75.2 Million0.5% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$32.2 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$31.2 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.78MShares$23.8 Million1.31% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.56MShares$21.8 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...